{
    "2021-10-31": [
        [
            {
                "time": "",
                "original_text": "上海医药前三季度净利润44.84亿元 同比增超24%",
                "features": {
                    "keywords": [
                        "上海医药",
                        "净利润",
                        "同比增长",
                        "24%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "10月上海医药、罗欣药业等多家公司引进新药 它们有何亮点？",
                "features": {
                    "keywords": [
                        "上海医药",
                        "罗欣药业",
                        "引进新药",
                        "10月"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}